Trademark: 87364438
Word
UNIVERSAL FUSION EXPRESSION
Status Date
Tuesday, March 12, 2019
Registration Number
5699440
Registration Date
Tuesday, March 12, 2019
Filing Date
Thursday, March 9, 2017
44 Medical diagnostic testing services in the field of human disease and human medical conditions; medical testing for diagnostic or treatment purposes; providing medical information to others in the field of human disease, human medical conditions, medical diagnostic testing services and medical testing for diagnostic or treatment purposes; providing an Internet website portal featuring medical information in the field of human disease, and human medical conditions, medical diagnostic testing services, medical testing for diagnostic or treatment purposes; providing cloud-based medical information to others in the field of human disease, human medical conditions, medical diagnostic testing services, and medical testing for diagnostic or treatment purposes; medical testing for the detection of cancer; medical testing for the detection of genetic information pertaining to human disease; medical diagnostic testing to aid in diagnosis, prognosis and therapy selection; oncology reference laboratory testing services for diagnostic or treatment purposes
42 Genetic mapping for scientific purposes; genetic mapping for scientific purposes, namely, gene sequencing; medical research, namely, molecular sequencing; cancer study and analysis; clinical study and testing of cells for medical research purposes; medical and scientific research information in the field of gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells; scientific research in the field of gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells, and cancer; providing scientific and medical research information to others in the fields of oncology, pathology and gene sequencing, molecular sequencing, cancer study and analysis, and clinical study and testing of cells; scientific testing and research services and clinical scientific testing in the fields of oncology, pathology, gene sequencing, molecular sequencing, human disease and human medical conditions; providing an Internet website portal featuring scientific and medical research information in the field of gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells; scientific and medical research information in the fields of scientific testing and research services, medical research services, and clinical scientific testing; providing cloud-based scientific and medical research information to others in the field of scientific testing and research services, medical research services, and clinical scientific testing; providing temporary use of online non-downloadable software for analysis of medical test results; providing temporary use of online non-downloadable software for enhancement of analysis, research and review of information pertaining to medical, scientific and genetic testing and analysis, and for providing information pertaining to such testing and analysis; software as a service (SAAS) services featuring software for analysis of medical test results; software as a service (SAAS) featuring software for enhancement of analysis, research and review of information pertaining to medical, scientific and genetic testing and analysis, and for providing information pertaining to such testing and analysis; providing medical research and scientific research information in the field of oncology; scientific and medical research in the field of genetic testing, RNA testing and sequencing; scientific testing and research services in the field of human disease and human medical conditions; providing medical research services in the field of human disease and human medical conditions; providing clinical scientific testing services and medical research and testing for medical research services in the field of human disease and human medical conditions; clinical research laboratory services in the field of human disease, human medical conditions, and oncology reference laboratory services for medical research purposes; providing scientific and medical research information, interactive information, and reports to others in the fields of pathology, diagnostic testing and oncology testing
Mar 12, 2024
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Feb 1, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Feb 1, 2023
Teas Change Of Correspondence Received
Feb 1, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 1, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 1, 2023
Teas Change Of Owner Address Received
Nov 10, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Nov 10, 2022
Teas Change Of Correspondence Received
Nov 10, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 10, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 10, 2022
Teas Change Of Owner Address Received
Jun 13, 2022
Teas Change Of Correspondence Received
Jun 13, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 13, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 3, 2019
Assignment Of Ownership Not Updated Automatically
Mar 12, 2019
Registered-Supplemental Register
Feb 6, 2019
Law Office Publication Review Completed
Feb 5, 2019
Assigned To Lie
Jan 29, 2019
Exparte Appeal Terminated
Jan 29, 2019
Approved For Registration Supplemental Register
Jan 26, 2019
Teas/Email Correspondence Entered
Jan 25, 2019
Correspondence Received In Law Office
Jan 25, 2019
Teas Response To Office Action Received
Aug 7, 2018
Notification Of Examiner's Amendment/Priority Action E-Mailed
Aug 7, 2018
Examiner's Amendment/Priority Action E-Mailed
Aug 7, 2018
Combined Examiner's Amendment/Priority Action Automatic Entry
Aug 7, 2018
Examiners Amendment And/Or Priority Action - Completed
Aug 7, 2018
Notice Of Acceptance Of Amendment To Allege Use E-Mailed
Aug 6, 2018
Use Amendment Accepted
Jul 18, 2018
Ex Parte Appeal-Instituted
Jul 18, 2018
Jurisdiction Restored To Examining Attorney
Jul 18, 2018
Exparte Appeal Received At Ttab
Jul 14, 2018
Teas/Email Correspondence Entered
Jul 14, 2018
Correspondence Received In Law Office
Jul 12, 2018
Teas Request For Reconsideration Received
Jul 12, 2018
Amendment To Use Processing Complete
Jul 12, 2018
Use Amendment Filed
Jul 11, 2018
Teas Amendment Of Use Received
Jan 18, 2018
Notification Of Final Refusal Emailed
Jan 18, 2018
Final Refusal E-Mailed
Jan 18, 2018
Final Refusal Written
Dec 27, 2017
Teas/Email Correspondence Entered
Dec 27, 2017
Correspondence Received In Law Office
Dec 21, 2017
Assigned To Lie
Dec 13, 2017
Teas Response To Office Action Received
Jun 13, 2017
Notification Of Non-Final Action E-Mailed
Jun 13, 2017
Non-Final Action E-Mailed
Jun 13, 2017
Non-Final Action Written
Jun 4, 2017
Assigned To Examiner
Mar 14, 2017
New Application Office Supplied Data Entered
Mar 13, 2017
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
